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Mesenchymal stem/stromal cells (MSCs) are
heterogeneous. A fraction of these cells constitute
multipotent cells that can self-renew and mainly give
rise to mesodermal lineage cells such as adipocytes,
osteocytes and chondrocytes. The ability of MSCs to
differentiate into endothelial cells remains
controversial. Isolation and in vitro manipulation of
MSCs before clinical application are important steps.
High numbers of MSCs are needed, requiring the
in vitro expansion of these clinically important cells. To
this end, a well-controlled procedure for MSC isolation
and maintenance in culture is necessary.cell medium upon enzymatic dissociation express, fiveA study published in the current issue of Stem Cell Re-
search and Therapy shows that the phenotypic charac-
teristics and multi-lineage differentiation efficiency of
mesenchymal stem/stromal cells (MSCs) derived from
human Wharton’s jelly (WJ) are dependent on the isola-
tion methods and culture conditions used [1]. MSCs are
multi-lineage mesodermal progenitor cells selected by
their capacity to adhere to plastic and proliferate in
long-term cultures of unfractionated cell suspensions.
Initially described in the adult bone marrow, MSCs now
can be derived from many other developing and adult
tissues including fat, skeletal muscle, dental pulp, pla-
centa and umbilical cord. MSCs have a defined pheno-
type, expressing the cell surface markers CD44, CD73,
CD90 and CD105. However, such a retrospective isola-
tion in vitro results in high cell heterogeneity in the cul-
ture dish, even more so since isolation procedures and
culture conditions differ significantly from one labora-
tory to another. Such differences in cell processing mayCorrespondence: m.crisan@erasmusmc.nl
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© 2013 BioMed Central Ltd.generate variable results, as evidenced by the present
study.
The endothelial differentiation potential of MSCs is
controversial and may depend on their tissue origin
[2,3]. Besides their capacity to differentiate into adipo-
cytes, bone and cartilage, which will not be discussed
here, Corotchi and colleagues compare in their study the
endothelial differentiation capacity of WJ-MSCs isolated
and cultured along distinct protocols [1]. Unfractionated
cells derived from WJ are either seeded directly into
endothelial cell medium or first cultured in xeno-free
MSC medium before endothelial cell medium, prior to
phenotypic and functional detection of endothelial cells.
Unfractionated WJ cells directly cultured in endothelial
passages later, endothelium-related genes and proteins
and form vascular networks in vitro. The emergence of
such endothelial cells could be due to contamination by
endothelial cells or progenitors upon isolation. Indeed,
endothelial cell marker mRNAs (very similar to that seen
in human endothelial cells derived from the umbilical
cord vein) are found in the cell suspension upon isola-
tion but before culture, although these are not detected
as proteins.
As extensively discussed by Corotchi and colleagues,
there is no clear evidence showing that WJ-MSCs are
able to differentiate into endothelial cells as previously
shown from other tissues [2-4]. Simultaneous isolation
of rare endothelial cells or endothelial progenitor cells
and MSCs from WJ could explain these results. Endo-
thelial cells would preferentially grow in these culture
conditions. Interestingly, after five passages in endothe-
lial cell medium, most WJ-derived cells not only express
the endothelial cell markers CD31, CD34, von
Willebrand factor, CD144, Tie-2, and vascular endothe-
lial growth factor receptors 1 and 2 (Flk1), but also typ-
ical MSC markers such as CD44, CD73 and CD105.
Intriguingly, CD90 is absent. Multicolor flow cytometry
analysis would provide further information about the
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markers. This information leads to raising questions of
whether some endothelial (progenitor) cells were able to
transdifferentiate toward MSCs and whether some MSCs
were truly able to differentiate into endothelial cells.
Transdifferentiation in both ways was indeed previously
reported in other systems [5,6].
It would be very interesting to know whether the mes-
enchymal–endothelial like cells described in this study
maintain their capacity to differentiate into adipocytes,
osteocytes and chondrocytes. Myoendothelial cells were
described in the adult human skeletal muscle, which
coexpress endothelial and myogenic cell markers and
can regenerate muscle [7]. Importantly, these myogenic
endothelial cells are also able to differentiate toward
bone and cartilage [8]. Hemogenic endothelial cells
coexpress hematopoietic and endothelial cell markers
and generate definitive self-renewing hematopoietic stem
cells in vivo (reviewed in [9]). However, the cells derived
by Corotchi and colleagues from human WJ and
coexpressing both endothelial and mesenchymal cell
markers are only described in culture. It would be inter-
esting to test whether a common mesenchymal–endo-
thelial progenitor is present in situ in human WJ, or
whether the presence of such cells is an artifact of cell
culture. A common progenitor for endothelial cells and
adipocytes has been reported in human white adipose
tissue [10].
A second culture condition was tested in this study to
determine whether WJ cells can differentiate into endo-
thelial cells. Corotchi and colleagues show that WJ-
MSCs do not differentiate into endothelial cells if they
are first cultured in xeno-free MSC medium followed by
endothelial cell medium. These observations were inde-
pendent of the protocol used for cell isolation. Endothe-
lial cell markers were completely absent and no
capillary-like structures developed in Matrigel [1]. In
contrast, all typical MSC markers were expressed. How-
ever, osteogenic, chondrogenic and adipogenic assays
were not performed after endothelial cell medium was
added. It would thus be informative to test whether the
multipotentiality of MSCs is maintained in these endo-
thelial cell culture conditions, as is the case in xeno-free
MSC medium.
The lack of endothelial differentiation of WJ-MSCs was
also recently reported [11]. Importantly, Choi and col-
leagues showed that WJ-MSCs cultured in these conditions
act as a perivascular niche and stabilize blood vessels
in vivo. Besides displaying an MSC phenotype, these WJ-
MSCs express perivascular cell markers and are found lo-
calized within the perivascular wall of newly formed func-
tional blood vessels when transplanted into an ischemic
mouse. In contrast, transplantation in the same mouse
model of human endothelial cells derived from theumbilical cord vein also gave rise to blood vessels but these
were not functional, suggesting a key paracrine function of
perivascular WJ-MSC-derived cells in vessel stabilization
[11]. These data are no surprise. The affiliation between
MSCs and perivascular cells in human tissues was recently
described [12]. Pericytes purified to homogeneity by flow
cytometry from multiple human organs and cultured over
the long term become indistinguishable from conventional
MSCs in terms of morphology, growth properties, pheno-
type, and developmental potential [12]. Pericytes/MSCs
were also derived from human pluripotent stem cells that,
upon transplantation into ischemic mouse limbs, promoted
vascular recovery and skeletal muscle regeneration [13].
Pericytes/MSCs did not differentiate into endothelial cells,
but were incorporated within the perivascular wall of de
novo formed functional blood vessels of host origin. More-
over, human pluripotent stem cell-derived pericytes can de-
velop in culture into chondrocytes, osteoblasts and
adipocytes similar to conventional MSCs and purified
pericytes. Similarly, perivascular cells purified from human
skeletal muscle improved cardiac anatomy and function
when transplanted into the ischemic mouse heart [14].
In conclusion, Corotchi and colleagues show that
isolation protocols and culture conditions can give
rise to different results, in terms of cell lineage de-
velopment, starting with the same unfractionated hu-
man WJ cells. The cells used by the authors are
highly heterogeneous upon initial isolation and dif-
ferent cell types can be enriched upon culture,
namely MSCs or endothelium. Whether MSCs differ-
entiate into endothelial cells remains controversial.
Interestingly, this group describes for the first time a
population of cells that coexpress endothelial and
mesenchymal cell markers. These are functional
endothelial cells but whether they can still differenti-
ate into adipocytes, chondrocytes and osteoblasts
was not tested. Phenotypically, these cells isolated
from human umbilical cord are reminiscent of
mesoangioblasts, the mesenchymal-like cells mainly
associated with the walls of large vessels. Although it
is thought that mesoangioblasts are similar to
pericytes of small vessels, they express endothelial
cell markers such as Flk-1 and are able to differenti-
ate into endothelial or mesodermal cell lineages [15].
Whether the mesenchymal–endothelial-like cells de-
scribed herein by Corotchi and colleagues emerge as
a consequence of culturing conditions or whether
they exist natively in vivo in human WJ prior to cul-
ture deserves further investigation.
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